Abstract
In the UK over 10,000 new cases of bladder cancer were diagnosed in 2012, making it the seventh most common cancer in the UK. For those with advanced disease at presentation, prognosis is poor. Disease presenting with one pathological node (N1) is considered to be Stage 4 and is therefore considered the same as disease with widespread metastases. Pelvic lymph node dissection is considered standard when performing radical cystectomy; however, owing to potential toxicity, pelvic radiotherapy is not routine even when attempting radical treatment. We present five cases where radical treatment has been delivered to patients with node-positive bladder cancer. Treatment volumes included the whole bladder and bilateral pelvic nodes, and where it was felt appropriate, chemotherapy was delivered concurrently. Data has been collected by reviewing hospital notes including radiotherapy, volumes and dose distributions. Treatment was tolerated well with only minimal gastrointestinal and urinary symptoms reported. Three of the five patients had thrombocytopenia. This complication may be explained by the larger volume of radiation exposure. Local control appears to be good with all the patients having no pelvic relapse at the time of reporting. Two patients have relapsed with distant metastatic disease. No long-term side effects of therapy have been reported. Intensity-modulated radiotherapy techniques allow larger volumes to be treated owing to improved conformality and the resulting reduced toxicity. Treatment may be appropriate with both radical and adjuvant doses of radiation. More work is necessary to assess which patients would benefit and are most suitable for such treatment.
Highlights
In the UK over 10,000 new cases of bladder cancer were diagnosed in 2012, making it the seventh most common cancer in the UK
Patients with lymph node involvement are considered to have a poorer prognosis after radical cystectomy and pelvic lymph node dissection but survival rates do vary
With Intensity-modulated radiotherapy (IMRT), pelvic radiation is more tolerable and we present five cases where radical treatment has been delivered to patients with node-positive bladder cancer
Summary
In the UK over 10,000 new cases of bladder cancer were diagnosed in 2012, making it the seventh most common cancer in the UK. James et al[6] reported local control rates of 67% at 2 years when concurrent chemotherapy was used with radical radiation doses. BJR|case reports treatment was well tolerated, with grade 3 or 4 Radiation Therapy Oncology Group (RTOG) adverse events occurring during follow-up in only 8.3% and 15.7% of patients in the chemoradiotherapy and radiotherapy groups respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have